Literature DB >> 15841309

Tissue plasminogen activator in central nervous system physiology and pathology.

Jerry P Melchor1, Sidney Strickland.   

Abstract

Although conventionally associated with fibrin clot degradation, recent work has uncovered new functions for the tissue plasminogen activator (tPA)/plasminogen cascade in central nervous system physiology and pathology. This extracellular proteolytic cascade has been shown to have roles in learning and memory, stress, neuronal degeneration, addiction and Alzheimer's disease. The current review considers the different ways tPA functions in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841309      PMCID: PMC1383744          DOI: 10.1160/TH04-12-0838

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  63 in total

1.  mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation.

Authors:  T Masos; R Miskin
Journal:  Brain Res Mol Brain Res       Date:  1997-07

2.  Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation.

Authors:  Serkan Oray; Ania Majewska; Mriganka Sur
Journal:  Neuron       Date:  2004-12-16       Impact factor: 17.173

3.  Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons.

Authors:  R N Pittman
Journal:  Dev Biol       Date:  1985-07       Impact factor: 3.582

4.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

Review 5.  Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling.

Authors:  D Collen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

6.  Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex.

Authors:  C M Müller; C B Griesinger
Journal:  Nat Neurosci       Date:  1998-05       Impact factor: 24.884

7.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

Authors:  M Yepes; M Sandkvist; M K Wong; T A Coleman; E Smith; S L Cohan; D A Lawrence
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation.

Authors:  Chan Y Shin; Mitchell Kundel; David G Wells
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

9.  Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition.

Authors:  H M Tucker; M Kihiko-Ehmann; S Wright; R E Rydel; S Estus
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

10.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

View more
  60 in total

1.  Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.

Authors:  Jung-Da Fang; Hsiao-Chin Chou; Hsiu-Hui Tung; Pao-Yi Huang; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

2.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

Review 3.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

4.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

5.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.

Authors:  Enming J Su; Linda Fredriksson; Melissa Geyer; Erika Folestad; Jacqueline Cale; Johanna Andrae; Yamei Gao; Kristian Pietras; Kris Mann; Manuel Yepes; Dudley K Strickland; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

6.  The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice.

Authors:  Ho Jung Bae; Jihyun Kim; Jaehoon Kim; Nayeon Goo; Mudan Cai; Kyungnam Cho; Seo Yun Jung; Huiyoung Kwon; Dong Hyun Kim; Dae Sik Jang; Jong Hoon Ryu
Journal:  Br J Pharmacol       Date:  2020-04-01       Impact factor: 8.739

7.  Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study.

Authors:  Anne Huotari; Soili M Lehto; Leo Niskanen; Karl-Heinz Herzig; Jukka Hintikka; Heli Koivumaa-Honkanen; Tommi Tolmunen; Kirsi Honkalampi; Noora Kaikkonen; Heimo Viinamäki
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-14

Review 8.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

Review 9.  Brain extracellular matrix in neurodegeneration.

Authors:  Dafna Bonneh-Barkay; Clayton A Wiley
Journal:  Brain Pathol       Date:  2008-07-25       Impact factor: 6.508

10.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.